News
Several experts are seeing that value of AI's total overhaul of healthcare, including beneficial additions such as generative ...
A feud is brewing over diversity, equity, and inclusion funding in Stockton. It has led the city's vice mayor, Jason Lee, to ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called MPLA, can be used as an adjuvant for an HIV vaccine under trial. An alum ...
In a study of mice, the researchers showed that this approach produced a much wider diversity of antibodies against an HIV antigen, compared to the vaccine given on its own or with just one of the ...
OmniAb, Inc. (NASDAQ: OABI) today announced its participation in the 21st Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway a ...
The antibody provided mice with full protection against five snakes — the black mamba and a mix of cobras. So Glanville and his colleagues wrote the journal Cell to gauge their interest in ...
SAN DIEGO — An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, according to a poster presented here. This molecular ...
“These anti-immune complex antibodies have not been studied in very much depth, especially in the context of HIV vaccination,” said Andrew Ward, PhD, professor of integrative structural and ...
The resulting fully human single-domain antibodies offer exceptional diversity, affinity, stability, and modularity, supporting broad therapeutic applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results